CoChat
Sign Up
Cited by 98Pharmaceutical Practices and Patient OutcomesPharmacy and Medical PracticesPharmacovigilance and Adverse Drug Reactions

ORCA: OpeRational ClassificAtion of Drug Interactions

Hansten, Philip D., Horn, John R., Hazlet, Thomas K.·2001·Journal of the American Pharmaceutical Association (1996)
DOI 10.1016/s1086-5802(16)31244-x
Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s1086-5802(16)31244-x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The panel used the Hansten and Horn operational classification scheme to reassign major drug-drug interactions to lower severity levels, decreasing interruptive alerting.

    “The panel uses the operational classification scheme described by Hansten and Horn to reassign major drug-drug interactions to lower severity levels, and thus decrease interruptive alerting [14].”

    From Drug interaction alert override rates in the Meaningful Use era: No evidence of progress (2014) · cites this paper as [14]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Hansten, P. D., Horn, J. R., & Hazlet, T. K.
Affiliations
University of Washington (US)
Corresponding author
Hansten, Philip D.
ORCID
Venue
Journal of the American Pharmaceutical Association (1996)
Publisher
Elsevier BV
Published
2001-03
Volume
41
Issue
2
Pages
161-165
ISSN
1086-5802 (ISSN-L)
DOI
10.1016/s1086-5802(16)31244-x
OpenAlex
W91312702
Cited by
98
References
13
Citations by year
2026: 2 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 6 · 2018: 1 · 2017: 5 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 13 · 2012: 11
FWCI
1.57
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the American Pharmaceutical Association (1996) (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
drug interactions, ORCA
MeSH terms
Drug Interactions, Drug Therapy, Computer-Assisted, Humans, Medication Errors, Software, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review